Megiorni, F., Camero, S., Ceccarelli, S., McDowell, H. P., Mannarino, O., Marampon, F., . . . Dominici, C. (2016). DNMT3B in vitro knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation. Oncotarget.
シカゴスタイル引用形Megiorni, Francesca, et al. "DNMT3B in Vitro Knocking-down Is Able to Reverse Embryonal Rhabdomyosarcoma Cell Phenotype Through Inhibition of Proliferation and Induction of Myogenic Differentiation." Oncotarget 2016.
MLA引用形式Megiorni, Francesca, et al. "DNMT3B in Vitro Knocking-down Is Able to Reverse Embryonal Rhabdomyosarcoma Cell Phenotype Through Inhibition of Proliferation and Induction of Myogenic Differentiation." Oncotarget 2016.